About Mme
MME is a renowned global leader in the development of value-based market access strategies and research for healthcare goods and services. The company has been providing its clients with innovative solutions to complex market access challenges for over a decade. MME's expertise lies in its ability to provide customized solutions that are tailored to meet the unique needs of each client.
One of the key strengths of MME is its team of highly skilled professionals who have extensive experience in health economics, outcomes research, pricing, reimbursement, and market access. The team comprises experts from diverse backgrounds such as academia, industry, consulting firms, and regulatory agencies. This diversity enables MME to bring a unique perspective to every project it undertakes.
MME's approach is based on a deep understanding of the healthcare landscape and the evolving needs of patients, payers, providers, and regulators. The company uses this knowledge to develop evidence-based strategies that help clients navigate complex market access challenges successfully.
MME offers a wide range of services that include health technology assessment (HTA), value proposition development, pricing strategy development, payer engagement strategy development, evidence generation planning and execution (including clinical trial design), systematic literature reviews (SLRs), network meta-analyses (NMAs), indirect treatment comparisons (ITCs), budget impact analyses (BIAs), cost-effectiveness analyses (CEAs) among others.
One area where MME has particularly excelled is PRMA - Patient-Reported Outcomes Measures Analysis. PRMA involves measuring patient-reported outcomes such as quality-of-life measures or symptom severity scores in clinical trials or observational studies. These measures can be used by decision-makers such as payers or regulators when evaluating new treatments' effectiveness compared with existing treatments or standard care.
MME's PRMA expertise has helped many clients gain approval for their products by demonstrating their value proposition effectively through robust evidence generation plans that incorporate patient-reported outcomes data into HTA submissions.
In addition to its core services mentioned above; MME also provides training programs on various topics related to market access such as HTA methodologies & processes; Pricing & Reimbursement Strategies; Payer Engagement Strategies; Evidence Generation Planning & Execution among others.
The company has worked with several leading pharmaceutical companies across different therapeutic areas such as oncology; rare diseases; cardiovascular diseases among others. Some notable projects include developing an innovative pricing strategy for an orphan drug targeting Gaucher disease which led to successful reimbursement negotiations with multiple European countries' authorities.
Another project involved conducting an SLR followed by NMA comparing different treatment options for advanced non-small cell lung cancer patients resulting in significant cost savings while maintaining similar efficacy levels compared with current standard care options available at that time.
In conclusion: If you're looking for expert guidance on navigating complex market access challenges successfully - look no further than MME! With over ten years' experience providing customized solutions tailored specifically towards each client's unique needs backed up by robust evidence generation plans incorporating patient-reported outcomes data into HTA submissions - they are well-positioned leaders within this field globally!
m2econ.com
